LINCOLN — LINCOLN PHARMACEUTICALS Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹11.66bn
- IN₹9.91bn
- IN₹5.10bn
- 92
- 39
- 82
- 86
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 622 | 672 | 837 | 959 | 1,005 |
Depreciation | |||||
Non-Cash Items | 25.9 | 6.72 | -24.6 | -58.8 | -85.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -186 | 1.84 | -196 | -220 | -618 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 528 | 754 | 693 | 761 | 393 |
Capital Expenditures | -149 | -76.9 | -87.5 | -455 | -143 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -32.5 | -232 | -555 | -326 | -224 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -182 | -309 | -642 | -781 | -366 |
Financing Cash Flow Items | -44.7 | -19.9 | -11.9 | -10.4 | -13.5 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -358 | -378 | -57.5 | -25.6 | -45 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -11.1 | 67.7 | -7.03 | -45 | -18.8 |